copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Chimeric antigen receptor T-cell therapy for T-cell acute . . . Chimeric antigen receptor (CAR) T-cell therapy is a new and effective treatment for patients with hematologic malignancies Clinical responses to CAR T cells in leukemia, lymphoma, and multiple myeloma have provided strong evidence of the antitumor activity of these cells
Fratricide-resistant CD7-CAR T cells in T-ALL - Nature Medicine We report a case series of 17 such patients who received autologous chimeric antigen receptor (CAR) T cells expressing an anti-CD7 CAR and an anti-CD7 protein expression blocker (PEBL), which
CAR T-cells for T-cell acute lymphoblastic leukemia CAR T-cells targeting CD19 antigen is a promising cancer immunotherapy obtaining excellent response rate in patients heavily pretreated for multiple relapses or chemo-resistant B cell leukemia and lymphoma
CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for . . . Patients with > 99% CD7 expression on blast cells will be eligible for anti-CD7 PEBL-CAR-T cell infusion This is a single-centre, phase I study to determine the efficacy and safety of CAR T-cell therapy in patients with high-risk T-ALL, refractory or relapsed T-ALL
Targeted CD7 CAR T-cells for treatment of T-Lymphocyte . . . Chimeric antigen receptor (CAR) T-cell therapy is a novel cell-based immunotherapy that has attracted considerable attention from researchers and healthcare professionals due to its outstanding therapeutic efficacy (1)